Bhubaneswar: The Odisha Drugs Controller Directorate has given city-based Noble Pharmacare Limited the licence to manufacture 0.5 ml Auto Disable (AD) syringes, official sources said.
These syringes are recommended by the WHO and UNICEF for mass immunization programmes because of their single-use nature.
“We saw the on-coming demand and revamped our existing production line to design an 0.5 ML syringe. We indigenously developed it and then applied for licence with the Central Drugs Standard Control Organisation (CDSCO),” said Subrat Garabadu, Managing Director of the company that was established in 1989 with technical collaboration of Germany-based PharmaPlan.
Bigger syringes lead to wastage of the vaccines, and hence these 0.5 ml syringes are required, he explained.
There are only three manufacturers of 0.5 ml auto-disable syringes in the country, he informed.
Last month, the Odisha State Medical Corporation Limited (OSMCL) floated tenders for procurement of 1.06 crore 0.5 ml AD syringes and there had been no bidders.
London: In an utterly embarrassing scandal, two British soldiers were caught having sex inside a…
Bhubaneswar: A businessman was burnt to death in a major fire in his garments shop…
Puri: With holy Kartik month coming to an end on Friday, the restrictions on the…
Chennai: The Odisha men’s hockey team is within one win of making history. Odisha came…
Mumbai: Bollywood’s 'Mr Perfectionist' Aamir Khan has been contemplating quitting the industry for quite some…
Balasore: Two minor girls reportedly drowned while trying to collect miniature boats from a pond…
Ahmedabad: The Central government’s resolve to clamp down on illegal drug trafficking in the country resulted…
Bhubaneswar: The School of Hotel Management, faculty of hospitality and tourism management of Siksha ‘O’…